Clinical Trial Update: Paricalcitol Compared to Maxacalcitol in Chronic Kidney Disease Patients With Secondary Hyperparathyroidism [Phase 2]

View source ↗

Summary

Phase 2 trial comparing paricalcitol to maxacalcitol in chronic kidney disease patients with secondary hyperparathyroidism has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hyperparathyroidism

Drugs mentioned

• Maxacalcitol (maxacalcitol)
• Paricalcitol (Zemplar) (paricalcitol)

Snippet

Sponsor: Abbott | Conditions: Secondary Hyperparathyroidism, Hemodialysis | Phase 2 | Status: COMPLETED | Results posted: 2011-06-17